| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.29B | +7.3% |
| R&D Expense | $1.20B | +0.0% |
| SG&A Expense | $4.01B | +3.6% |
| Operating Income | $2.54B | -29.5% |
| Interest Expense | $545.0M | +7.7% |
| Pre-tax Income | $2.35B | -59.8% |
| Income Tax | $290.0M | -69.1% |
| Net Income | $2.06B | -58.0% |
| EPS (Basic) | $13.57 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.11B | +20.6% |
| Accounts Receivable | $1.45B | -3.8% |
| Inventory | $1.11B | +13.4% |
| Current Assets | $13.71B | +9.8% |
| Total Assets | $46.54B | +6.4% |
| Current Liabilities | $11.94B | +3.1% |
| Long-term Debt | $13.86B | +7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.88B | +33.6% |
| Capital Expenditures | $1.77B | +23.7% |
| Investing Cash Flow | -$1.58B | -27.5% |
| Financing Cash Flow | -$1.76B | +32.6% |
| Free Cash Flow | $2.10B | +43.2% |
| -57.1% |
| EPS (Diluted) | $13.53 | -57.0% |
| Total Liabilities |
| $31.75B |
| +11.6% |
| Stockholders' Equity | $14.79B | -3.4% |